Medpage Today on MSN5d
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, DeathGLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...
Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule ...
Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...
Terns Pharmaceuticals’ decision to drop its liver disease ambitions may yet pay off, after the biotech posted phase 1 data ...
GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...
The FDA said this after conducting a preliminary evaluation earlier this year of the drug class following some reports of suicidality and self-harm with GLP-1 agonists, but didn't find evidence ...
A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback